Morning Watch List: Mirati Therapeutics, Inc. (NASDAQ:MRTX), INSYS Therapeutics (NASDAQ:INSY), Global Partners (NYSE:GLP), Zion Oil & Gas (NASDAQ:ZN), Bank of America (NYSE:BAC)

Mirati Therapeutics, Inc. (NASDAQ:MRTX) announced they have entered into an exclusive clinical trial collaboration (“Collaboration Agreement”). The Phase I/II study will evaluate the safety and efficacy of Mirati’s investigational spectrum-selective histone deacetylase (HDAC) inhibitor, mocetinostat, in combination with MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, durvalumab (MEDI4736). This novel combination will initially be evaluated in patients with non-small cell lung cancer (NSCLC), with the potential to explore additional indications in the future. Mirati Therapeutics, Inc. (NASDAQ:MRTX) belongs to Healthcare sector. Its weekly performance is -1.38%. On last trading day company shares ended up $27.12. Mirati Therapeutics, Inc. (NASDAQ:MRTX) distance from 50-day simple moving average (SMA50) is -12.88%.

INSYS Therapeutics, Inc. (NASDAQ:INSY) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmaceutical cannabidiol (CBD) candidate for the treatment of infantile spasms (IS). INSYS Therapeutics, Inc. (NASDAQ:INSY) shares fell -10.71% in last trading session and ended the day at $39.95. INSY Gross Margin is 90.40% and its return on assets is 19.10%. INSYS Therapeutics, Inc. (NASDAQ:INSY) quarterly performance is 44.88%.

On 06 August, Global Partners LP (NYSE:GLP) reported financial results for the second quarter ended June 30, 2015. “Our second-quarter performance reflects our diverse business,” said Eric Slifka, the Partnership’s President and Chief Executive Officer. “Our Gasoline Distribution and Station Operations (GDSO) segment contributed a product margin of $98.3 million for the second quarter, an increase of 56 percent from the same period in 2014, primarily reflecting our January acquisition of Warren Equities. Our Wholesale segment product margin was $60.9 million, compared with $34.5 million in the same period of 2014.” Global Partners LP (NYSE:GLP) shares advanced 0.99% and was closed at $30.54. GLP EPS growth in last 5 year was 9.50%. Global Partners LP (NYSE:GLP) year to date (YTD) performance is -2.12%.

On July 29, Zion Oil & Gas, Inc. (NASDAQ:ZN) announced that under our Dividend Reinvestment and Common Stock Purchase Plan (“DSPP” or the “Plan”), we are extending the Unit Option under the unit program. Our Unit Option is being extended from the original termination date of May 4, 2015 to a termination date of December 31, 2015. Zion Oil & Gas, Inc. (NASDAQ:ZN) ended the last trading day at $1.72. Company weekly volatility is calculated as 3.46% and price to cash ratio as 13.05. Zion Oil & Gas, Inc. (NASDAQ:ZN) showed a weekly performance of 4.24%.

Bank of America Corporation (NYSE:BAC) is pulling its wealthy clients’ money from one of billionaire John Paulson’s hedge funds and reviewing another because of concern that large positions may be hard to sell. Bank of America Corporation (NYSE:BAC) belongs to Financial sector. Its net profit margin is 20.70% and weekly performance is -1.77%. On last trading day company shares ended up $17.81. Bank of America Corporation (NYSE:BAC) distance from 50-day simple moving average (SMA50) is 2.58%.

Leave a Reply

Your email address will not be published. Required fields are marked *